https://ugisense.com/en/meet-us-at-the-bio-europe-spring-2026-ugisense-will-attend-the-bio-europe-spring-2026-march-23-25-2026-lisbon-portugal/2026-02-26daily0.8https://ugisense.com/en/about/team/2025-10-29daily0.8https://ugisense.com/en/meet-us-at-the-tides-europe-2025-ugisense-will-attend-the-tides-europe-11-13-november-basel-switzerland/2025-10-21daily0.8https://ugisense.com/en/meet-us-at-the-bio-europe-2025-ugisense-will-attend-the-bio-europe-2025-november-3-5-vienna-austria/2025-10-21daily0.8https://ugisense.com/en/meet-us-at-the-ots-annual-meeting-2025-ugisense-will-attend-the-ots-annual-meeting-october-19-22-budapest-hungary/2025-10-21daily0.8https://ugisense.com/en/technology/2024-05-16daily0.8https://ugisense.com/en/meet-us-at-bioequity-europe-2023-ugisense-will-attend-the-bioequity-europe-2023-may-15-16-2023-dublin-ireland/2024-05-16daily0.8https://ugisense.com/en/meet-us-at-bio-europe-spring-2024-ugisense-will-attend-the-bio-europe-spring-2024-march-18-20-2024-barcelona-spain/2024-05-16daily0.8https://ugisense.com/en/meet-us-at-meet2win-oncology-partnering-convention-ugisense-will-attend-the-meet2win-oncology-partnering-convention-may-16-17-2024-bordeaux-france/2024-05-16daily0.8https://ugisense.com/en/about/2024-05-13daily0.8https://ugisense.com/en/pipeline/2024-05-12daily0.8https://ugisense.com/en/pipeline/cancer-indications/2024-05-12daily0.8https://ugisense.com/en/about/ugisense/2024-05-12daily0.8https://ugisense.com/en/about/board/2024-05-12daily0.8https://ugisense.com/en/meet-us-at-bio-europe-spring-2023-ugisense-will-attend-the-bio-europe-spring-2023-march-20-22-2023-basel-switzerland-2/2023-03-09daily0.8https://ugisense.com/en/meet-us-at-bioequity-2022-ugisense-will-attend-bioequity-2022-which-will-take-place-in-17-18-may-2022-in-milan/2022-05-10daily0.8https://ugisense.com/en/oligonucleotide-production-for-future-blockbuster-applications-is-challenging-2/2022-04-29daily0.8https://ugisense.com/en/news-ugisense-boehringer-ingelheim/2022-03-24daily0.8https://ugisense.com/en/ugisense-ag-raises-its-series-b-round-to-advance-its-oncology-program-towards-pre-clinical-and-clinical-development/2021-05-01daily0.8https://ugisense.com/en/ldc-and-ugisense-ag-to-collaborate-on-new-drug-class/2021-05-01daily0.8https://ugisense.com/en/ugisense-ag-secures-new-financing/2021-05-01daily0.8https://ugisense.com/en/16th-annual-meeting-of-the-oligo-nucleotide-therapeutics-society-27-30-september-2020-2/2020-09-11daily0.8https://ugisense.com/en/bio-europe-2/2020-09-11daily0.8https://ugisense.com/en/imprint/2020-09-11daily0.8https://ugisense.com/en/investors/2020-09-01daily0.8https://ugisense.com/en/2020-06-16daily0.8https://ugisense.com/en/news/2020-06-07daily0.8https://ugisense.com/en/privacy/2020-06-07daily0.8https://ugisense.com/en/contact/2020-06-07daily0.8https://ugisense.com/en/careers/2020-06-07daily0.8